Outcomes Among 196 Patients With Noninfectious Proximal Aortitis.
Journal
Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
04
10
2017
accepted:
27
11
2018
pubmed:
8
2
2019
medline:
10
3
2020
entrez:
8
2
2019
Statut:
ppublish
Résumé
Noninfectious aortitis may occur in the context of a recognized systemic disease or as a topographically limited lesion without systemic features, which is called clinically isolated aortitis (CIA). This study was undertaken to better define and stress the limitations of this diagnostic category in a large population of patients in a single center dedicated to aortic diseases and to suggest recommendations for care. Records of patients undergoing thoracic aortic surgery (1996-2012) at the Cleveland Clinic were reviewed to identify 196 patients with histopathologically proven aortitis. Clinical diagnoses (giant cell arteritis [GCA], Takayasu arteritis [TAK], CIA, or Other) were determined at the time of surgery. Clinical features, laboratory findings, and imaging results were recorded throughout the follow-up period. At least 6 months of follow-up data were available for 73 CIA patients. The mean age of the patients at time of surgery was 65.6 years (range 15-88 years); 67% of patients were female, and 90.3% were white. At the time of surgery, 129 patients (65.8%) met criteria for CIA, 42 (21.4%) for GCA, 14 (7.1%) for TAK, and 11 (5.6%) met criteria for other systemic inflammatory diseases. During a mean follow-up period of 56.2 months, 19% of CIA patients developed new symptoms, 45% developed new radiographic vascular lesions, 40% underwent additional vascular surgery, and 12% died (n = 9). Eleven of 73 patients (15%) initially classified as having CIA developed features of a systemic disease, most often GCA. The majority of patients (66%) with histopathologically proven aortitis have CIA at the time of surgery. CIA patients infrequently report new symptoms over time, but new vascular lesions requiring surgery commonly occur. Serial follow-up including large vessel imaging is strongly advised for all aortitis patients.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2112-2120Informations de copyright
© 2019, American College of Rheumatology.
Références
Absi TS, Sundt TM III, Tung WS, Moon M, Lee JK, Damiano RR Jr, et al. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 2003;126:344-57.
Lillvis JH, Erdman R, Schworer CM, Golden A, Derr K, Gatalica Z, et al. Regional expression of HOXA4 along the aorta and its potential role in human abdominal aortic aneurysms. BMC Physiol 2011;11:9.
Hoffman GS. Determinants of vessel targeting in vasculitis. Clin Dev Immunol 2004;11:275-9.
Dal Canto AJ, Swanson PE, O'Guin AK, Speck SH, Virgin HW. IFN-γ action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest 2001;107:R15-22.
Haimovici H, Maier N, Strauss L. Fate of aortic homografts in experimental canine atherosclerosis: study of fresh thoracic implants into abdominal aorta. AMA Arch Surg 1958;76:282-8.
Haimovici H, Maier N, Strauss L. Fate of aortic homografts in experimental canine atherosclerosis. II. Study of fresh abdominal aortic implants into abdominal aorta. AMA Arch Surg 1959;78:239-45.
Haimovici H, Maier N. Fate of aortic homografts in canine atherosclerosis. III. Study of fresh abdominal and thoracic aortic implants into thoracic aorta: role of tissue susceptibility in atherogenesis. Arch Surg 1964;89:961-9.
Jackman JD Jr, Radolf JD. Cardiovascular syphilis. Am J Med 1989;87:425-33.
Cargile JS III, Fisher DF Jr, Burns DK, Fry WJ. Tuberculous aortitis with associated necrosis and perforation: treatment and options. J Vasc Surg 1986;4:612-5.
Hernández-Rodríguez J, Hoffman GS. Updating single-organ vasculitis. Curr Opin Rheumatol 2012;24:38-45.
Stone JR, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L, et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology. I. Inflammatory diseases. Cardiovasc Pathol 2015;24:267-78.
Cinar I, Wang H, Stone JR. Clinically isolated aortitis: pitfalls, progress and possibilities [review]. Cardiovasc Pathol 2017;29:23-32.
Rojo-Leyva F, Ratliff NB, Cosgrove DM III, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 2000;43:901-7.
Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry MC, Tazelaar HD. Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on isolated variant. Am J Surg Pathol 2006;30:1150-8.
Wang H, Smith RN, Spooner AE, Isselbacher EM, Cambria RP, MacGillivray TE, et al. Giant cell aortitis of the ascending aorta without signs or symptoms of systemic vasculitis is associated with an elevated risk of distal aortic events. Arthritis Rheum 2012;64:317-9.
Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, et al, for the Infliximbab-GCA Study Group. Infliximab for maintenance of glucocorticosteroid-induced remission of giant-cell arteritis: a randomized trial. Ann Intern Med 2007;146:621-30.
Visvanathan S, Rahman MU, Hoffman GS, Xu S, García-Martínez A, Segarra M, et al. Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis: a prospective longitudinal study. Rheumatology (Oxford) 2011;50:2061-70.
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1-11.
Kerr LD, Chang YJ, Spiera H, Fallon JT. Occult active giant cell aortitis necessitating surgical repair. J Thorac Cardiovasc Surg 2000;120:813-5.
Liang KP, Chowdhary VR, Michet CJ, Miller DV, Sundt TM, Connolly HM, et al. Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol 2009;36:2290-7.
Homme JL, Aubry MC, Edwards WD, Bagniewski SM, Shane Pankratz V, Kral CA, et al. Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 2006;30:1159-68.
Pacini D, Leone O, Turci S, Camurri N, Giunchi F, Martinelli GN, et al. Incidence, etiology, histologic findings, and course of thoracic inflammatory aortopathies. Ann Thorac Surg 2008;86:1518-23.
Schmidt J, Sunesen K, Kornum JB, Duhaut P, Thomsen RW. Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study. Arthritis Res Ther 2011;13:R87.
Ryan C, Barbour A, Burke L, Sheppard MN. Non-infectious aortitis of the ascending aorta: a histological and clinical correlation of 71 cases including overlap with medial degeneration and atheroma: a challenge for the pathologist. J Clin Pathol 2015;68:898-904.
Svensson LG, Arafat A, Roselli EE, Idrees J, Clifford A, Tan C, et al. Inflammatory disease of the aorta: patterns and classification of giant cell aortitis, Takayasu arteritis and non-syndromic aortitis. J Thorac Cardiovasc Surg 2015;149 Suppl:S170-5.